MIND Diet Intervention and Cognitive Decline
Launched by RUSH UNIVERSITY MEDICAL CENTER · Jun 25, 2016
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND) is a Phase III randomized controlled trial designed to test the effects of a 3-year intervention of a hybrid of the Mediterranean and DASH diets, called MIND, on cognitive decline among 600 individuals 65+ years without cognitive impairment who are overweight and have suboptimal diets. The proposed MIND diet is a hybrid of the Mediterranean and DASH diets but with selected modifications based on the most compelling evidence in the diet-dementia field. The MIND diet has the same basic components of the DASH and Mediterra...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • family history of dementia
- • BMI \>=25
- • suboptimal diet
- Exclusion Criteria:
- • heavy alcohol use
- • severe illness
- • cognitively impaired
- • psychiatric illness
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Chicago, Illinois, United States
Patients applied
Trial Officials
Lisa L Barnes, Ph.D.
Principal Investigator
Rush University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials